SVRA - サバラ (Savara Inc.)

SVRAのニュース

   Savara enters into $26.5M debt refinancing agreement with Silicon Valley Bank  2022/04/22 12:56:02 Seeking Alpha
Savara entered into a $26.5M term loan agreement with Silicon Valley Bank to replace its existing credit facility with the bank.
   Savara GAAP EPS of -$0.07 in-line  2022/03/30 21:20:37 Seeking Alpha
Savara press release (SVRA): Q4 GAAP EPS of -$0.07 in-line.As of December 31, 2021, the Company had cash, cash equivalents and short-term investments of $161.2 million.
   Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update  2022/03/30 20:05:00 Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, reported financial results for the fourth quarter and full year ending December 31, 2021 and provided a business update. “The company underwent a significant amount of positive change in 2021. We streamlined the pipeline to focus solely on the molgramostim development program, strengthened our management team with key hires in clinical, regulatory, and CMC and improved our financial position with a $130M
   Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference  2022/03/09 13:05:00 Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 16, 2022 at 3:20 pm ET. A live webcast of the presentation will be available on Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. About Savara Savara is a clinical stage biopharmaceutical
   Savara Inc (NASDAQ:SVRA) Director Acquires $28,250.00 in Stock  2021/12/20 11:10:42 Transcript Daily
Savara Inc (NASDAQ:SVRA) Director David A. Ramsay acquired 25,000 shares of the companys stock in a transaction dated Friday, December 17th. The stock was acquired at an average price of $1.13 per share, for a total transaction of $28,250.00. The purchase was disclosed in a legal filing with the SEC, which is available at the []
   Savara Inc (NASDAQ:SVRA) Director Acquires $28,250.00 in Stock  2021/12/20 11:10:42 Transcript Daily
Savara Inc (NASDAQ:SVRA) Director David A. Ramsay acquired 25,000 shares of the companys stock in a transaction dated Friday, December 17th. The stock was acquired at an average price of $1.13 per share, for a total transaction of $28,250.00. The purchase was disclosed in a legal filing with the SEC, which is available at the []
   Brokerages Anticipate Savara Inc (NASDAQ:SVRA) Will Announce Earnings of -$0.07 Per Share  2021/12/19 00:56:41 Dakota Financial News
Wall Street brokerages forecast that Savara Inc (NASDAQ:SVRA) will report earnings per share of ($0.07) for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Savaras earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.06). The business is expected to issue its next quarterly earnings report on Friday, []
   Savara Inc (NASDAQ:SVRA) Director Acquires $36,400.00 in Stock  2021/12/13 22:30:42 Dakota Financial News
Savara Inc (NASDAQ:SVRA) Director David A. Ramsay bought 35,000 shares of the firm’s stock in a transaction on Friday, December 10th. The stock was bought at an average cost of $1.04 per share, for a total transaction of $36,400.00. The purchase was disclosed in a legal filing with the SEC, which is available through this […]
   Companies - Goldman Sachs Group Inc. Has $236,000 Position in Savara Inc  2021/12/11 09:15:09 Business Mag
Goldman Sachs Group Inc. increased its position in shares of Savara Inc by 44.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities
   Goldman Sachs Group Inc. Has $236,000 Position in Savara Inc (NASDAQ:SVRA)  2021/12/11 09:10:44 ETF Daily News
Goldman Sachs Group Inc. increased its position in shares of Savara Inc (NASDAQ:SVRA) by 44.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 138,907 shares of the companys stock after purchasing an additional 42,886 shares during the period. Goldman Sachs [] The post Goldman Sachs Group Inc. Has $236,000 Position in Savara Inc (NASDAQ:SVRA) appeared first on ETF Daily News .
   Stocks Volume Buzz: Savara Inc. (NASDAQ:SVRA), Solitario Zinc Corp. (AMEX:XPL)  2021/07/06 04:26:42 Stock Equity
Savara Inc. (NASDAQ:SVRA) with the stream of -3.05% also noticed, India Solitario Zinc Corp. (AMEX:XPL) encountered a rapid change of 1.75% in the last hour of Mondays trading session. Savara The post Stocks Volume Buzz: Savara Inc. (NASDAQ:SVRA), Solitario Zinc Corp. (AMEX:XPL) appeared first on Stocks Equity .
   Savara doses first patient in late-stage rare lung disease trial  2021/06/30 14:54:20 Seeking Alpha
   Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial  2021/06/30 14:47:00 Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the first patient has been dosed in the pivotal IMPALA-2 clinical trial. IMPALA-2 is a Phase 3 trial designed to evaluate the efficacy and safety of molgramostim compared to placebo. Molgramostim is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). The trial is expected to be conduct
   Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR)  2021/06/18 23:06:00 Stock Equity
Savara Inc. (NASDAQ:SVRA) with the stream of -1.09% also noticed, India Blonder Tongue Laboratories, Inc. (AMEX:BDR) encountered a rapid change of 0.00% in the last hour of Fridays trading session. The post Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR) appeared first on Stocks Equity .
   Savara: They Failed Once, But They Are Trying Again  2021/06/07 19:03:54 Seeking Alpha

calendar